Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674769 | SCV000800162 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-05-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001042038 | SCV001205696 | pathogenic | not provided | 2023-10-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu3811Metfs*5) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is present in population databases (no rsID available, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 558490). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003453388 | SCV004182102 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453387 | SCV004182104 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003453388 | SCV005055737 | likely pathogenic | Retinitis pigmentosa 39 | 2024-01-22 | criteria provided, single submitter | clinical testing |